Tag Archives: The State of Patent Eligibility

Neapco’s Brief in Opposition to AA’s Petition for Cert.

On March 31, 2021, Neapco Holdings LLC filed its Brief in Opposition to American Axle’s Petition for Cert. If you need a refresher on the proceedings to date, please read (or re-read) the analyses I posted on Jan. 11, 2021 … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

In re: Board of Trustees of Stanford: “Big Data” Personalized Medicine is an Abstract Idea

In re: Board of Trustees of the Leland Stanford Junior University, Appeal no. 2020-1012 (Federal Circuit, March 11, 2021) a three judge panel of Prost, Lurie and Reyna affirmed the ruling by the Board of Appeals that the claims of … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , | Leave a comment

XY, LLC v. Trans Ova Genetics, Inc. – Building on Illumina v. Ariosa

In XY v. Trans Ova Genetics, Inc., Appeal No. 2019-1789 (Fed. Cir. July 31, 2020), a panel of Wallach, Plager and Stoll reversed the district court’s finding that claims to an improved method of cell sorting are patent ineligible under … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

AAM v. Neapco – Part IV – Petition for Rehearing En Banc Denied – “Bad Vibrations”

This post will briefly discuss the Fed. Cir.’s denial of rehearing en banc – which  left the modified panel opinion stand. The lengthy panel opinion has been the subject of my last three posts, and you should read them before … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment